Literature DB >> 26768265

Management approaches for suspected and established Lyme disease used at the Lyme disease diagnostic center.

Gary P Wormser1, Donna McKenna2, John Nowakowski2.   

Abstract

2015 marks the 27th year that the Lyme Disease Diagnostic Center, located in New York State in the United States, has provided care for patients with suspected or established deer tick-transmitted infections. There are five deer tick-transmitted infectious in this geographic area of which Lyme disease is the most common.For patients with erythema migrans, we do not obtain any laboratory testing. However, if the patient is febrile at the time of the visit or reports rigors and high-grade fevers, we consider the possibility of a co-infection and order pertinent laboratory tests.Our preferred management for Lyme disease-related facial palsy and/or radiculopathy is a 2-week course of doxycycline. Patients who are hospitalized for Lyme meningitis are usually treated at least initially with ceftriaxone. We have not seen convincing cases of encephalitis or myelitis solely due to Borrelia burgdorferi infection in the absence of laboratory evidence of concomitant deer tick virus infection (Powassan virus). We have also never seen Lyme encephalopathy or a diffuse axonal peripheral neuropathy and suggest that these entities are either very rare or nonexistent.We have found that Lyme disease rarely presents with fever without other objective clinical manifestations. Prior cases attributed to Lyme disease may have overlooked an asymptomatic erythema migrans skin lesion or the diagnosis may have been based on nonspecific IgM seroreactivity. More research is needed on the appropriate management and significance of IgG seropositivity in asymptomatic patients who have no history of Lyme disease.

Entities:  

Keywords:  Borrelia; Lyme borreliosis; Lyme disease

Mesh:

Substances:

Year:  2016        PMID: 26768265     DOI: 10.1007/s00508-015-0936-y

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  28 in total

1.  Treatment of the early manifestations of Lyme disease.

Authors:  A C Steere; G J Hutchinson; D W Rahn; L H Sigal; J E Craft; E T DeSanna; S E Malawista
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

2.  Brief communication: hematogenous dissemination in early Lyme disease.

Authors:  Gary P Wormser; Donna McKenna; Jennafer Carlin; Robert B Nadelman; L Frank Cavaliere; Diane Holmgren; Daniel W Byrne; John Nowakowski
Journal:  Ann Intern Med       Date:  2005-05-03       Impact factor: 25.391

3.  Intraarticular corticosteroids in refractory childhood Lyme arthritis.

Authors:  S Nimmrich; I Becker; G Horneff
Journal:  Rheumatol Int       Date:  2014-01-04       Impact factor: 2.631

4.  Neutropenia in Congenital and Adult Babesiosis.

Authors:  Gary P Wormser; Patrick Villafuerte; Sheila M Nolan; Guiqing Wang; Robert G Lerner; Kirsten L Saetre; Mazen H Maria; John A Branda
Journal:  Am J Clin Pathol       Date:  2015-07       Impact factor: 2.493

5.  Comparison of a quantitative PCR assay with peripheral blood smear examination for detection and quantitation of Babesia microti infection in humans.

Authors:  Guiqing Wang; Patrick Villafuerte; Jian Zhuge; Paul Visintainer; Gary P Wormser
Journal:  Diagn Microbiol Infect Dis       Date:  2015-03-18       Impact factor: 2.803

6.  Borrelia miyamotoi Disease in the Northeastern United States: A Case Series.

Authors:  Philip J Molloy; Sam R Telford; Hanumara Ram Chowdri; Timothy J Lepore; Joseph L Gugliotta; Karen E Weeks; Mary Ellen Hewins; Heidi K Goethert; Victor P Berardi
Journal:  Ann Intern Med       Date:  2015-07-21       Impact factor: 25.391

7.  Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.

Authors:  Erica Weitzner; Donna McKenna; John Nowakowski; Carol Scavarda; Rhea Dornbush; Susan Bittker; Denise Cooper; Robert B Nadelman; Paul Visintainer; Ira Schwartz; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2015-09-18       Impact factor: 9.079

8.  Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.

Authors:  Gary P Wormser; Maria E Aguero-Rosenfeld; Mary E Cox; John Nowakowski; Robert B Nadelman; Diane Holmgren; Donna McKenna; Susan Bittker; Lois Zentmaier; Denise Cooper; Dionysios Liveris; Ira Schwartz; Harold W Horowitz
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

9.  Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.

Authors:  A P van Dam; H Kuiper; K Vos; A Widjojokusumo; B M de Jongh; L Spanjaard; A C Ramselaar; M D Kramer; J Dankert
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

10.  Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients.

Authors:  Dustin Brisson; Nilofer Baxamusa; Ira Schwartz; Gary P Wormser
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

View more
  5 in total

1.  Lyme borreliosis, ticks and Borrelia species.

Authors:  Gerold Stanek
Journal:  Wien Klin Wochenschr       Date:  2018-08       Impact factor: 1.704

Review 2.  A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease.

Authors:  Gary P Wormser; Franc Strle; Eugene D Shapiro; Raymond J Dattwyler; Paul G Auwaerter
Journal:  Diagn Microbiol Infect Dis       Date:  2016-11-12       Impact factor: 2.803

Review 3.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132

4.  Integrated Social-Behavioral and Ecological Risk Maps to Prioritize Local Public Health Responses to Lyme Disease.

Authors:  Catherine Bouchard; Cécile Aenishaenslin; Erin E Rees; Jules K Koffi; Yann Pelcat; Marion Ripoche; François Milord; L Robbin Lindsay; Nicholas H Ogden; Patrick A Leighton
Journal:  Environ Health Perspect       Date:  2018-04-18       Impact factor: 9.031

Review 5.  Human Co-Infections between Borrelia burgdorferi s.l. and Other Ixodes-Borne Microorganisms: A Systematic Review.

Authors:  Pierre H Boyer; Cédric Lenormand; Benoît Jaulhac; Emilie Talagrand-Reboul
Journal:  Pathogens       Date:  2022-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.